Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Celularity Inc

CELU ✗ NOT COMPLIANT ☆ Track — members

Nasdaq · Healthcare · Pharmaceuticals ·

USA Micro Cap Analyst: N/A

Last Close

$0.70

▲ +0.07%

Market Cap $20.14M · Vol 1.03K

Key Metrics

P/E Ratio

N/A

FWD: N/A

Market Cap

$20.14M

Micro Cap

Div Yield

N/A

EPS Growth

N/A

YoY

RSI (14)

41.81

Momentum

Beta

0.57

vs Market

52W High

$4.25

83.61% below

52W Low

$0.57

22.93% above

Volume

1.03K

Avg 13.93K

P/B

N/A

Price-to-book

ROE

N/A

Return on equity

Free Float

62.72%

Public shares

Shariah Compliance8 STANDARDS

✗ Celularity Inc (CELU) stock is currently not Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See which standards it fails, the exact ratios behind the verdict, and halal alternatives. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does CELU pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+1.52%

-7.84%

-14.25%

-45.64%

YTD

-37.32%

-79.89%

-77.75%

-98.93%

Financials & Valuation

TTM · Annual

Total Revenue	$26.55M
Net Income	$-91,716,000.00
Revenue Growth (YoY)	-77.37%
Gross Margin	18.77%
Operating Margin	-230.92%
Net Profit Margin	-345.45%
ROE	N/A
ROA · ROIC	-76.42% · N/A

P/E Ratio	N/A
Forward P/E (FY1)	N/A
PEG Ratio	N/A
P/S	1.07
P/B	N/A
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	28.95M

Technical Indicators

50-Day SMA	$0.73
200-Day SMA	$1.18
RSI (14)	41.81
Beta	0.57
52-Week High	$4.25
52-Week Low	$0.57

Volume Today	1.03K
Avg Daily Volume (30D)	13.93K
Relative Volume	0.07x
Volatility (10D)	55.69
Volatility (30D)	97.67
Free Float	62.72%

Analyst Consensus

N/A

Current Price $0.70

Mean Target $6.00

52W Low$0.57 52W High$4.25

Current

Target

$0.57 $4.25

Current Analyst target

+762.32% upside potential · 0 analysts

Identifiers

ExchangeNasdaq

FIGIBBG00P2RTT43

ISINUS1511902041

CountryUnited States of America

Sub-IndustryBiopharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

REGN Regeneron Pharmaceuticals Inc -0.31% 207940.KS Samsung Biologics Co Ltd -1.02% UCB.BR Ucb SA -3.10% CSL.AX CSL Ltd -0.74% BIIB Biogen Inc -0.39%

Company Profile

Celularity Inc. is a regenerative and cellular medicine company. The Company is developing and commercializing advanced biomaterial products and allogeneic, cryopreserved, placental-derived cell therapies, all derived from the postpartum placenta. Its therapeutic programs target aging-related diseases, including degenerative diseases, cancer, and immune disorders, using mesenchymal-like adherent stromal cells, T-cells engineered with CAR (CAR T-cells), and genetically modified and unmodified natural killer (NK) cells. Its IMPACT manufacturing platform is a fully integrated process designed to optimize the speed of the sourcing of placentas from full-term healthy informed consent donors through the use of proprietary processing methods, cell selection, product-specific chemistry, manufacturing and control (CMC), advanced cell manufacturing and cryopreservation. It also provides contract manufacturing and development services to third parties.